Literature DB >> 6786117

Salmonella paratyphi A in hamsters concurrently infected with Schistosoma mansoni.

I A Mikhail, G I Higashi, N S Mansour, D C Edman, S H Elwan.   

Abstract

The present work deals with the development of an improved animal model to study the association of salmonellosis and schistosomiasis. The animal chosen was the hamster, Mesocricetus auratus, which can be readily infected with Schistosoma mansoni. Normal hamsters and schistosome-infected hamsters (SIH) were given approximately 2.0 x 10(7) Salmonella paratyphi A intracardially. It was found that S. mansoni infections enhanced and prolonged the growth of S. paratyphi A in hamsters. Animals with dual infections had increased mortality in comparison with those infected with just bacteria or parasite during the 50 days post-bacterial challenge. Further studies showed that in SIH, S. paratyphi A persisted in various organs for up to 8 weeks post infection. In contrast, concurrent Leishmania donovani infections have no effect on S. paratyphi A infections. Significant numbers of bacteria were cultured from well-washed schistosome worms recovered from SIH 6--8 weeks post-bacterial challenge. These findings suggest that a direct physical relationship between the bacteria and worms facilitates the establishment and growth of S. paratyphi A in vivo, and that a deficit in host immune response is not a major factor involved in the enhanced growth of S. paratyphi A.

Entities:  

Mesh:

Year:  1981        PMID: 6786117     DOI: 10.4269/ajtmh.1981.30.385

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  2 in total

1.  Mechanism of interaction of Salmonella and Schistosoma species.

Authors:  R F Melhem; P T LoVerde
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

Review 2.  Schistosome: its benefit and harm in patients suffering from concomitant diseases.

Authors:  Yoshio Osada; Tamotsu Kanazawa
Journal:  J Biomed Biotechnol       Date:  2011-11-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.